SCHEMBL20072326

SCHEMBL20072326

C#CCCCCCCCCCCC(C)[C@H](O)C[C@H](O)COC(C)=O

nearest known ligand 0.75

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
USP2 O75604 6/20 0.75
CYP3A4 P08684 4/20 0.75
MAPT P10636 4/20 0.75
ALDH1A1 P00352 3/20 0.75
MEN1 O00255 1/20 0.75
TP53 P04637 1/20 0.75
MAPK1 P28482 1/20 0.75
KMT2A Q03164 1/20 0.75
SMN1; SMN2 Q16637 3/20 0.46
HPGD P15428 2/20 0.46
KDM4E B2RXH2 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP2D6 P10635 1/20 0.33
CYP2C9 P11712 1/20 0.33
CYP2C19 P33261 1/20 0.33
HSD17B10 Q99714 1/20 0.33
TRPV1 Q8NER1 1/20 0.31
ALOX5 P09917 2/20 0.30
LMNA P02545 1/20 0.30
RECQL P46063 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Avocadyne Acetate SCHEMBL12235380 0.86 USP2 (1.00) USP2CYP3A4MAPTALDH1A1MEN1
Avocadyne Acetate SCHEMBL12235379 0.86 USP2 (1.00) USP2CYP3A4MAPTALDH1A1MEN1
SCHEMBL20072469 0.86 USP2 (1.00) USP2CYP3A4MAPTALDH1A1MEN1
Avocadyne Acetate SCHEMBL1164203 0.86 USP2 (1.00) USP2CYP3A4MAPTALDH1A1MEN1
Avocadyne Acetate SCHEMBL31368571 0.86 USP2 (1.00) USP2CYP3A4MAPTALDH1A1MEN1
SCHEMBL20072187 0.84 USP2 (0.80) USP2CYP3A4MAPTALDH1A1MEN1
SCHEMBL20072443 0.81 USP2 (0.79) USP2CYP3A4MAPTALDH1A1MEN1
Avocadyne Acetate SCHEMBL25216029 0.77 USP2 (1.00) USP2CYP3A4MAPTALDH1A1MEN1
SCHEMBL20072286 0.75 USP2 (0.73) USP2CYP3A4MAPTALDH1A1MEN1
SCHEMBL20063072 0.74 USP2 (0.76) USP2CYP3A4MAPTALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10932484-B2 Inhibitory activity of acetogenins against Listeria monocytogenes INSTITUTO TECNOLOGICO Y DE ESTUDIOS SUPERIORES DE MONTERREY (MX) 2021-03-02 US disclosed
US-20180103671-A1 INHIBITORY ACTIVITY OF ACETOGENINS AGAINST LISTERIA MONOCYTOGENES INSTITUTO TECNOLOGICO Y DE ESTUDIOS SUPERIORES DE MONTERREY (MX) 2018-04-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180103671-A1 INHIBITORY ACTIVITY OF ACETOGENINS AGAINST LISTERIA MONOCYTOGENES LTN1, LCT, LSS USP2 1358/4885CYP3A4 4070/4885MAPT 3556/4885
US-10932484-B2 Inhibitory activity of acetogenins against Listeria monocytogenes LTN1, LCT, LSS USP2 1358/4885CYP3A4 4070/4885MAPT 3556/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.